Last reviewed · How we verify
NCT04614805
Timely Reperfusion in Acute ST-segment Myocardial Infarction
trial testing Mobilizing clinical leaders in Acute Myocardial Infarction in 146 participants. Completed in 4 January 2023.
4 January 2023
Quick facts
| Lead sponsor | University Hospital of North Norway |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 146 |
| Start date | 1 November 2020 |
| Primary completion | 4 January 2023 |
| Estimated completion | 4 January 2023 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Mobilizing clinical leaders
Conditions studied
- Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →
Sponsor
University Hospital of North Norway
Who can join
Eligibility, any sex, with Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Barriers to Rapid Reperfusion in Acute ST-Elevation Myocardial Infarction.
Bartnes K, Albrigtsen H, Iversen JM, Brovold H, et al · · 2022 · cited 3× · PMID 36203049 · DOI 10.1007/s40119-022-00281-7
Verify or expand the search:
- PubMed search for NCT04614805
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Myocardial Infarction
Currently open trials in the same condition.
- NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
- NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
- NCT06947135 — Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury · NA · recruiting
- NCT06515730 — Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction · Phase 4 · recruiting
- NCT07522164 — Acute Myocardial Infarction Clinical Cohort · active not recruiting
Other University Hospital of North Norway trials
Trials by the same sponsor.
- NCT07343895 — Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tromsø Study · NA · recruiting
- NCT07149246 — The Effect of a 6-month Dietitian-tailored Nutrition Intervention to Patients With Critical Illness (DETAIL) · NA · recruiting
- NCT07092904 — Myocardial Infarction Safe Emergency Medicine Accompanying Study: Providing Reperfusion Therapy Within the Recommended T · not yet recruiting
- NCT07530588 — Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis · NA · recruiting
- NCT06881758 — High Intensity Training for Patients with Anxiety · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04614805 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital of North Norway
- Last refreshed: 6 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04614805.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing